Le Lézard
Classified in: Health
Subjects: LAW, PLW

Caldwell Cassady & Curry Helps Acantha Win $8.2 Million Patent Infringement Verdict Against Medical Device Giant DePuy Synthes


GREEN BAY, Wisc., Aug. 23, 2018 /PRNewswire/ -- The Dallas-based intellectual property and business litigation law firm Caldwell Cassady & Curry has won an $8.2 million patent infringement verdict for Acantha LLC against medical device manufacturer DePuy Synthes, a subsidiary of health care giant Johnson & Johnson (NYSE: JNJ).

A jury of five women and three men issued the unanimous verdict on Aug. 21, 2018, following seven days of trial before the Hon. Chief Judge William C. Griesbach in the U.S. District Court for the Eastern District of Wisconsin in Green Bay. Jurors reached their verdict following five hours of deliberations.

DePuy Synthes was sued in 2015 based on claims that it had infringed an Acantha patent, U.S. Patent No. RE43,008 ('008 patent), which covers an orthopedic implant assembly used to join bone segments. Acantha's '008 patent was originally issued in 2001 before being reissued in 2011 by the U.S. Patent and Trademark Office.

The Caldwell Cassady & Curry trial team representing Acantha at trial included Brad Caldwell, Austin Curry, Chris Stewart, John Summers and Seth Reich.

Jurors heard evidence that David Talaber, one of the two co-inventors of the '008 patent, informed DePuy Synthes's predecessors about the patent in writing and by phone the year after it was issued.

Mr. Talaber's co-inventor, Dr. James Lloyd, later traveled to DePuy's Massachusetts headquarters in 2006 to explain how Acantha's patent could help with problems DePuy experienced with its implant devices. The DePuy companies never licensed the patent.

Acantha asserted that DePuy Synthes subsequently infringed the '008 patent in a series of spine implant devices, including the Zero-P VA System and the Vectra, Vectra-T, and Vectra-One products.

The Green Bay jury found that the DePuy companies willfully infringed Acantha's patent, awarding $8.2 million in actual damages. The case is Acantha LLC v. DePuy Synthes Sales Inc., et al., No. 1:15-CV-01257.

Caldwell Cassady & Curry represents companies and individuals in high-stakes civil litigation, including patent infringement cases, trade secrets claims, fiduciary duty cases, class actions, and disputes involving company founders. The firm has tried and won some of the nation's top verdicts against the largest companies in the world. For more information, visit www.caldwellcc.com.

For more information, contact Bruce Vincent at 214-763-6226 or [email protected].

 

SOURCE Caldwell Cassady & Curry


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: